Diagnosing Diabetic Neuropathy: Something Old, Something New

There are potentially many ways of assessing diabetic peripheral neuropathy (DPN). However, they do not fulfill U.S. Food and Drug Administration (FDA) requirements in relation to their capacity to assess therapeutic benefit in clinical trials of DPN. Over the past several decades symptoms and signs...

Descripción completa

Detalles Bibliográficos
Autores principales: Petropoulos, Ioannis N., Ponirakis, Georgios, Khan, Adnan, Almuhannadi, Hamad, Gad, Hoda, Malik, Rayaz A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107364/
https://www.ncbi.nlm.nih.gov/pubmed/30136449
http://dx.doi.org/10.4093/dmj.2018.0056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107364/
https://www.ncbi.nlm.nih.gov/pubmed/30136449
http://dx.doi.org/10.4093/dmj.2018.0056

Ejemplares similares